Opinion by Richard Sternberg COVID: Good News/Bad News Six weeks ago, I wrote about a new drug called malnupiravir from Merck that was a game changer in the treatment of COVID-19. When taken in the first few days of infection it was 50% effective in the prevention of hospitalization and death. While not as good as monoclonal antibodies this was considered an amazing result and the study was terminated early in order to immediately ask for emergency approval. It was…
Online home of The Freeman's Journal and Hometown Oneonta
Advertisement
malnupiravir
Opinion by Richard Sternberg M.D. There is good news to report on COVID prevention Last week, Merck and Company announced that an experimental pill they are working on to treat COVID-19 early in the course of the disease to keep patients from becoming seriously ill or dying is proving safe and effective. After discussion with the FDA, it and Merck felt the results were so good they decided to close additional enrollment to the trial. They will finish out the…
